AJAY SHESHADRI to Graft vs Host Disease
This is a "connection" page, showing publications AJAY SHESHADRI has written about Graft vs Host Disease.
Connection Strength
1.274
-
A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. Immunohorizons. 2023 Jun 01; 7(6):421-430.
Score: 0.396
-
Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease. Blood Adv. 2022 09 13; 6(17):4984-4986.
Score: 0.377
-
Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients. Bone Marrow Transplant. 2021 03; 56(3):745-748.
Score: 0.329
-
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther. 2021 10; 27(10):817-835.
Score: 0.086
-
Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease. Transplant Cell Ther. 2021 07; 27(7):616.e1-616.e6.
Score: 0.085